41
/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
May 31, 2026
3776316
934019
1
Public Timelines
FAQ

Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expected in 1H 2025 Trial Continues with Full Data and FDA Regulatory Path Feedback Expected in 1H 2025 SLS009 (2h 56min, jun 18, 2026 y – jun 30, 2025)

Added to timeline:

11 months ago
0
0
1628

Date:

2h 56min, jun 18, 2026 y
jun 30, 2025
~ 11 months